Member access

4-Traders Homepage  >  Shares  >  Mercado Continuo Espanol  >  Grifols SA    GRF   ES0171996012

GRIFOLS SA (GRF)

56
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercado Continuo Espanol
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
36.86(c) 37.395(c) 37.365(c) 37.745(c) 37.515(c) Last
582 679 1 042 315 2 090 415 461 246 346 969 Volume
+1.32% +1.45% -0.08% +1.02% -0.61% Change
More quotes
Financials (€)
Sales 2015 3 742 M
EBIT 2015 938 M
Net income 2015 534 M
Debt 2015 3 272 M
Yield 2015 1,69%
Sales 2016 4 004 M
EBIT 2016 1 042 M
Net income 2016 606 M
Debt 2016 2 978 M
Yield 2016 1,92%
PER 2015 23,82
PER 2016 21,13
EV / Sales 2015 4,05x
EV / Sales 2016 3,71x
Capitalization 11 877 M
More Financials
Company
Grifols SA is a vertically integrated global producer of plasma derivatives.Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers.The company operates through four segments: Bioessence,... 
Sector
Pharmaceuticals
Calendar
05/28 | 06:00amShareholder meeting
More about the company
Surperformance© ratings of Grifols SA
Trading Rating : Investor Rating :
More Ratings
Latest news on GRIFOLS SA
05/11 GRIFOLS : Aradigm Announces First Quarter 2015 Financial Results
05/07 GRIFOLS : rsquo; net profit up by +6.2% to 128.5 million euros and sales grow by..
05/05 GRIFOLS : a healthcare company participates in White House Upskill Summit
04/24 GRIFOLS : Drive nets 11,000 pounds of PB&J for Clayton food pantry
03/30 GRIFOLS : In Clayton, a push for PB&J
03/29 GRIFOLS : to make a major equity investment in Alkahest
03/09 GRIFOLS : to make a major equity investment in Alkahest
03/04 GRIFOLS : to make a major equity investment in Alkahest Download (380.5 Kb)
More news
Sector news : Biopharmaceuticals
05/22DJAmgen Ends Psoriasis-Drug Partnership With AstraZeneca -- Update
05/22 AMGEN : ends work on experimental psoriasis drug
05/22DJAmgen Ends Psoriasis-Drug Partnership With AstraZeneca
More sector news : Biopharmaceuticals
News from SeekingAlpha
05/21 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
03/31 Is The Elixir Of Youth Closer Than We Think? A New Way Of Viewing Blood Produ..
03/02 TIGENIX : Locked And Loaded For Phase 3 Readout
02/23 Tracking John Paulson's Paulson & Company Portfolio - Q4 2014 Update


Comments 
Advertisement
Chart GRIFOLS SA
Duration : Period :
Grifols SA Technical Analysis Chart | GRF | ES0171996012 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions